The StarMine team has selected five North American companies, using Thomson Reuters’ Eikon Screener, that we expect to miss 17Q3 earnings estimates, based on SmartEstimate® and Predicted Surprise data.
Our North American selections for 2017 Q2 misses were 62.2 percentage points above the S&P 500’s 17Q2 earnings miss rate, which can be seen here. Historically (since 2011 Q4), our picks have demonstrated an accuracy rate of about 64.6%, giving investors an edge ahead of earnings announcements.
Our North American picks for negative Predicted Surprises in 2017 Q3 are — Medicines Co (MDCO.O), Tourmaline Oil Corp (TOU.TO), Voyager Therapeutics Inc (VYGR.O), Green Plains Inc (GPRE.O), FARO Technologies Inc (FARO.O).
SmartEstimates® aim to provide earnings forecasts that are more accurate than I/B/E/S Consensus Estimates, by putting more weight on the recent forecasts of top-rated analysts. When SmartEstimates® diverge significantly from Consensus, you can anticipate the occurrence of earnings surprises with an accuracy rate of 70%. Revenue SmartEstimates® are even more predictive of surprises, with a historical accuracy rate of 78%.
Medicines Co (MDCO.O)
Tourmaline Oil Corp (TOU.TO)
Voyager Therapeutics Inc (VYGR.O)
Green Plains Inc (GPRE.O)
FARO Technologies Inc (FARO.O)
Republication or redistribution of Reuters content, including by framing or similar means, is prohibited without the prior written consent of Reuters. Reuters and the Reuters logo are registered trademarks, and trademarks of the Thomson Reuters group of companies. For additional information on Reuters photographic services, please visit the web site at http://pictures.reuters.com
Which 5 North American companies does our StarMine team predict will beat 17Q3 earnings expectations? Find out here.